Skip to main content

Bezlotoxumab beats placebo at preventing recurrent C. difficile infections in high-risk patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Bezlotoxumab beats placebo at preventing recurrent C. difficile infections in high-risk patients

User login

Username

Password

Reset your password

Type	Lead	score